Introduction {#s1}
============

Hypertension is a major risk factor of stroke, cardiovascular disease, and end-stage renal disease and affects about 1 billion adults worldwide, including 3.8 million in Taiwan and 160 million in China [@pone.0065863-Kuo1]. Stroke is a primary contributor to long-term adult disability and the third most common cause of death in developed countries [@pone.0065863-Dichgans1], [@pone.0065863-Roger1]. Blood pressure-lowering therapies are viewed as protective measures against the risk of hypertension and stroke, but both genetic and lifestyle factors are likely involved in the development of these conditions.

Guanine nucleotide-binding proteins (G proteins) are key determinants of specific and temporal characteristics of many signaling processes and are expressed in all cells of the human body to primarily transduce signals from the cell surface into a cellular response. G proteins consist of α, β, and γ subunits and different genes encode for 18 α subunits, 5 β subunits, and 12 γ subunits, which enable the formation of highly variable heterotrimers [@pone.0065863-Siffert1]. Activation of a G protein-coupled receptor results in an exchange of guanosine triphosphate for guanosine diphosphate followed by dissociation of the α subunit from the βγ complex. Different α subunits can then regulate a large variety of intracellular signaling cascades. The α subunit and βγ complex then reassemble as a heterotrimer available for a new activation cycle [@pone.0065863-Klenke1]. Reportedly, the α, β, γ subunit composition of G proteins determine the receptor and effector specificities of particular heterotrimers. Thus, alterations in G protein signaling can cause multiple disorders and it is likely that functionally important genetic polymorphisms in genes that encode human G protein subunits can cause or contribute to various disease phenotypes.

The G protein beta polypeptide 3 (*GNB3*) gene encodes the Gβ3 subunit of heterotrimeric G proteins and is located on chromosome 12p13 and comprises 11 exons and 10 introns. A polymorphism (C825T, rs5433) was found to be associated with a shortened splice variant of the Gβ3 protein that gives rise to enhanced signal transduction via pertussis toxin-sensitive G proteins [@pone.0065863-Turner1], [@pone.0065863-Siffert2]. The C825T polymorphism located in exon 10 is in close linkage disequilibrium with the A(-350)G promoter single nucleotide polymorphism (SNP) and the C1429T SNP and can serve as a marker for allele-specific GNB3 expression. However, differential G protein activities associated with the C825T SNP did not result from different transcript amounts associated with specific GNB3 genotypes [@pone.0065863-Sun1].

Several epidemiological studies have shown an association between the *GNB3* 825T allele and other features of metabolic syndrome, including obesity, insulin resistance, changes in autonomic nervous function, and dyslipidemia. This polymorphism has also been identified in hypertension, stroke, Alzheimer's disease, sudden death, tumor progression, and as a genetic marker for drug responses to diuretics, antidepressants, and the antihypertension medications sildenafil, clonidine, and sibutramine [@pone.0065863-Lee1]--[@pone.0065863-Zhang1].

Recently, many groups have investigated the relationship between the *GNB3* C825T polymorphism and hypertension or stroke; however, the results have been inconclusive. Therefore, we designed the present meta-analysis to better clarify the association between the *GNB3* C825T polymorphism and hypertension or stroke.

Materials and Methods {#s2}
=====================

Literature Search {#s2a}
-----------------

This meta-analysis followed the PRISMA (preferred reporting items for systematic reviews and meta-analyses) criteria [@pone.0065863-Moher1]. We comprehensively searched for related papers in the following electronic databases: PubMed (up to Nov 2012), Embase (1996 to Nov 2012), Web of Science (2003 to Nov 2012), CBM (China Biology Medicine, 1978 to Jul 2012) and CNKI (China National Knowledge Infrastructure, 1999 to Nov 2012) using various keywords, including "hypertension," "stroke," "cerebral hemorrhage," "cerebrovascular disorder," "cerebrovascular disease," "mutation," "variant," "polymorphism," "ischemic stroke," "GNB3," "G protein beta," and "G-beta." Then, we manually searched the relevant journals and co-authors listed in the included studies to find additional studies. Reference lists of all retrieved publications were also checked for missing information. Meeting abstracts, which were previously shown to influence meta-analytical results [@pone.0065863-McAuley1], were also scrutinized. All relevant articles were initially scanned on the basis of title, keywords, and abstract. If this was not possible, the full text was obtained for further evaluation. The literature retrieval was performed independently by three investigators (LG, LLZ, and BZ) and discrepancies were resolved by reaching a consensus among the investigators. If a consensus could not be established, a fourth reviewer (JCL) was consulted to resolve the discrepancy. The last database searches were performed on November 10, 2012.

Inclusion Criteria {#s2b}
------------------

Studies were screened that met the following criteria: (1) population-based or hospital-based case-control studies regarding the relationship between the *GNB3* C825T polymorphism and essential hypertension or stroke; (2) sufficient data on genotypic and allelic frequencies to determine an odds ratio (OR) with a 95% confidence interval (CI). If multiple publications reported the same or overlapping data, the most recent or complete study or the largest population was included in this meta-analysis as described by Little et al. [@pone.0065863-Little1]; (3) to avoid local literature bias, publications in both Chinese and English were considered [@pone.0065863-Pan1]; (4) studies with related clinical characteristics were limited to those using human subjects; (5) articles regarding cases compounded with other diseases, such as diabetes mellitus and myocardial infarction, were also included; and (6) if patient blood pressure was measured casually or ambulatory (24 h), the latter were used. Hypertension was defined as mean casual blood pressure ≥140/90 mmHg or mean ambulatory blood pressure \>134/79 mmHg.

Data Extraction {#s2c}
---------------

Data were independently extracted from each study by three investigators (LG, LLZ, and BZ) following the above-mentioned inclusion criteria. Discordance was resolved by discussion or another reviewer (JCL) was consulted. The following data were collected from each of the selected studies: surname of the first author, year of publication, country of origin, population ethnicity, source of control, T allele frequency in controls, genotype variance in the cases and controls, and the Hardy--Weinberg equilibrium (HWE) using the χ^2^ test. A *p*-value of \<0.05 for the HWE was considered statistically significant.

Quality Score Assessment {#s2d}
------------------------

The quality of each selected study was assessed independently by the same three investigators according to the Newcastle--Ottawa Scale (NOS) ([www.ohri.ca/programs/clinical_epidemiology/oxford.asp](http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp)). Scores were based on the selection, comparability, and exposure (case-control studies) or outcome (cohort studies) of the studies. To avoid selection bias, studies of poor quality were not rejected in this meta-analysis.

Statistical Analysis {#s2e}
--------------------

All statistical analyses were conducted using Stata statistical software ver. 11.0 (Stats Corp., College Station, TX, USA) and Review Manager ver. 5.0 (The Cochrane Collaboration, Oxford, UK). All tests were two-sided and a *p*-value \<0.05 was considered statistically significant. The strength of association of the *GNB3* C825T polymorphism with hypertension or stroke was measured by calculating summary ORs with corresponding 95% CIs for the dominant model (TT+CT vs. CC), recessive model (TT vs. CT+CC), and allelic model (T allele vs. C allele), respectively.

Heterogeneity between the studies was analyzed using the Cochran's Q test and the I^2^ statistic (range, 0--100%) [@pone.0065863-Higgins1], [@pone.0065863-Petiti1]. If the results of the Q test was *p*\<0.1 and the measure of I^2^ was \>50%, indicating significant heterogeneity between studies, the ORs were pooled using a fixed effects Mantel--Haenszel method [@pone.0065863-Mantel1], otherwise the DerSimonian and Laird random effects model was adopted [@pone.0065863-DerSimonian1], [@pone.0065863-DerSimonian2]. A Galbraith plot was employed to detect potential sources of heterogeneity [@pone.0065863-Galbraith1]. The pooled ORs were recalculated after removing outlier studies identified by the Galbraith plots. To further detect heterogeneity, subgroup analyses were performed using the status of the HWE (yes or no) or the control source.

Sensitivity analysis was conducted by limiting the meta-analysis to high quality studies (NOS score ≥8). We also performed the analyses a second time by limiting the studies according to the HWE and excluding those that included myocardial infarction, obesity, or diabetes mellitus in the cases or controls. Sensitivity analysis was performed to identify alterations in the overall significance of the estimate.

Cumulative meta-analysis was performed to identify the influence of the first published study on the subsequent publications concerning the relationship between the *GNB3* C825T polymorphism and hypertension, and to estimate the combined estimate over time [@pone.0065863-Ioannidis1].

Publication bias was assessed using the Egger\'s regression test and Begg\'s test. The Egger's test detects funnel plot asymmetry by determining whether the intercept deviates significantly from zero in a regression of the standardized effect estimates against their precision [@pone.0065863-Begg1], [@pone.0065863-Egger1]. These methods were based on plotting the estimate (logOR) against the corresponding standard error (SE).

Results {#s3}
=======

Study Selection and Characteristics {#s3a}
-----------------------------------

The present study met the PRISMA statement requirements ([Appendix S1](#pone.0065863.s001){ref-type="supplementary-material"}). Through comprehensive retrieval and evaluation, 66 studies (20,782 cases and 26,141 controls) regarding hypertension and eight studies (3,427 cases and 3,948 controls) regarding stroke met the inclusion criteria and were included in the final meta-analysis. Details of the included studies are presented in [Tables 1](#pone-0065863-t001){ref-type="table"} and [2](#pone-0065863-t002){ref-type="table"} and the selection process is shown in [Figure 1](#pone-0065863-g001){ref-type="fig"}.

![A flow diagram of the literature search for associations between the *GNB3* C825T polymorphism and hypertension (A) or stroke (B).](pone.0065863.g001){#pone-0065863-g001}

10.1371/journal.pone.0065863.t001

###### The main characteristics of included studies regarding the association between the *GNB3* C825T polymorphism and hypertension.

![](pone.0065863.t001){#pone-0065863-t001-1}

  Author                                          Year      Country       Ethnicity   Sample sizeHT/Control, n   HT/Control, n   HT/Control, n   HEWY/N    T frequencyin control   SOCPB/HB    Score               
  ---------------------------------------------- ------ ---------------- ----------- -------------------------- --------------- --------------- --------- ----------------------- ----------- ------- ------- ---- ---
  rand [@pone.0065863-Brand1]                     2003      Belgian       Caucasian           352/1160              173/542         151/511      28/107          497/1595           207/725      Y     0.313   PB   9
  Shioji [@pone.0065863-Shioji1]                  2003       Japan          Asian             775/1105              177/287         385/536      213/282         739/1110          811/1100      Y     0.498   PB   8
  Dong [@pone.0065863-Dong1]                      1999       London        African            185/243                3/14            61/83       121/146          67/111            303/375      Y     0.772   PB   8
  Yamamoto [@pone.0065863-Yamamoto1]              2004       Japan          Asian             266/540               70/162          120/239      76/139           260/563           272/517      N     0.479   PB   8
  Hayakawa [@pone.0065863-Hayakawa1]              2007       Japan          Asian             156/271                42/82          76/121        38/68           160/285           152/257      Y     0.474   HB   9
  Khamidullaeva [@pone.0065863-Khamidullaeva1]    2011       Uzbek          Asian              174/60                64/0            93/50        17/10           221/50            127/70       Y     0.583   PB   9
  Hui [@pone.0065863-Hui1]                        2007       Japan          Asian             261/271                78/72          115/148       68/51           271/292           251/250      Y     0.461   PB   9
  Alioglu [@pone.0065863-Alioglu1]                2008       Turkey         Asian              209/82                37/27          124/40        48/15           198/94            220/70       Y     0.427   PB   8
  Kato [@pone.0065863-Kato1]                      1998       Japan          Asian             718/515               187/128         359/263      172/124          733/519           703/511      Y     0.496   PB   9
  Tsai [@pone.0065863-Tsai1]                      2000       China          Asian             302/199                57/43          149/96        96/60           263/182           341/216      Y     0.543   PB   9
  Kedzierska [@pone.0065863-Kedzierska1]          2006       Poland       Caucasian            26/18                 9/15            12/2          5/1             30/32             22/4        Y     0.111   HB   9
  Hager [@pone.0065863-Hager1]                    2011      Finland       Caucasian            74/48                 32/24           27/19        15/5             91/67             57/29       Y     0.302   HB   8
  Marcun Varda [@pone.0065863-MarcunVarda1]       2006      Slovenia      Caucasian           104/200               53/104           42/80        9/16            148/288           60/112       Y     0.280   HB   9
  Holmen [@pone.0065863-Holmen1]                  2010       Norway       Caucasian          1661/1175              863/630         682/465      116/80          2408/1725          914/625      Y     0.266   PB   9
  Tozawa [@pone.0065863-Tozawa1]                  2001       Japan          Asian             179/180                32/39           68/82        79/59           132/160           226/200      Y     0.556   HB   8
  Wang [@pone.0065863-Wang2]                      2004       Kazak          Asian             264/244                76/67          129/119       59/58           281/253           247/235      Y     0.482   PB   8
  Buchmayer [@pone.0065863-Buchmayer1]            2000     Australia      Caucasian           174/174                85/72           70/85        19/17           240/229           108/119      Y     0.342   PB   8
  Yamagishi [@pone.0065863-Yamagishi1]            2006       Japan          Asian             640/792               159/156         321/415      160/221          639/727           641/857      Y     0.541   PB   9
  Beige [@pone.0065863-Beige1]                    1999      Germany       Caucasian           479/900               204/514         224/312       51/74          632/1340           326/460      N     0.256   PB   9
  Zychma [@pone.0065863-Zychma1]                  2000       Poland       Caucasian            85/68                 32/24           44/36         9/8            108/84             62/52       Y     0.382   PB   8
  Benjafieid [@pone.0065863-Benjafield1]          1997     Australia      Caucasian           110/189               27/101           71/82        12/6            125/284            95/94       N     0.249   PB   8
  Li(a) [@pone.0065863-Li2]                       2005       China          Asian             501/503               142/137         256/259      103/107          540/533           462/473      Y     0.470   PB   8
  Suwazono [@pone.0065863-Suwazono1]              2006       Japan          Asian             218/1052              47/345          121/719      50/288          215/1409          221/1295      N     0.479   PB   9
  Ishikawa(a) [@pone.0065863-Ishikawa1]           2000       Japan          Asian             304/422                43/37           90/85        48/43           184/159           186/171      Y     0.518   HB   9
  Ishikawa(b) [@pone.0065863-Ishikawa1]           2000       Japan          Asian             181/165                67/96          161/204      76/122           295/396           313/448      Y     0.531   HB   9
  Bae [@pone.0065863-Bae1]                        2007       Korea          Asian             687/924               193/217         319/469      175/238          705/903           669/945      Y     0.511   PB   9
  Panoulas [@pone.0065863-Panoulas1]              2009      Britain       Caucasian           269/114               128/50          113/54        28/10           369/154           169/74       Y     0.325   HB   8
  Huang [@pone.0065863-Huang2]                    2003       China          Asian             585/580               134/126         290/303      161/151          558/555           612/605      Y     0.522   PB   9
  Larson [@pone.0065863-Larson1]                  2000      America        African            472/432                29/25          190/170      253/237          248/220           696/644      Y     0.745   PB   8
  Suwazono [@pone.0065863-Suwazono2]              2004       Japan          Asian             332/2289              78/574         171/1216      83/499          327/2364          337/2214      N     0.484   PB   8
  Brand [@pone.0065863-Brand2]                    1999   France/Ireland   Caucasian           206/467               98/226          92/197        16/44           288/649           124/285      Y     0.305   PB   8
  Nejatizadeh [@pone.0065863-Nejatizadeh1]        2011        Iran          Asian             449/345               185/192         211/144       53/9            581/528           317/162      N     0.235   PB   9
  Pitsavos [@pone.0065863-Pitsavos1]              2006       Greece       Caucasian           136/239               65/126           60/86        11/27           190/338           82/140       N     0.293   PB   8
  Izawa [@pone.0065863-Izawa1]                    2003       Japan          Asian             574/533               138/159         291/261      145/113          567/579           581/487      Y     0.457   PB   9
  Ozkececi [@pone.0065863-Ozkececi1]              2008       Turkey         Asian              99/45                 35/26           51/15        13/4            121/67             77/23       Y     0.256   PB   8
  Yin [@pone.0065863-Ruixing1]                    2009       China          Asian             257/865               60/224          126/424      71/217           246/872           268/858      Y     0.496   PB   9
  Vasudevan [@pone.0065863-Vasudevan1]            2009     Malaysian        Asian              70/75                 19/20           32/44        19/11            70/84             70/66       Y     0.440   PB   8
  Dong [@pone.0065863-Dong2]                      2006       China          Asian              97/87                 25/27           47/46        25/14           97/100             97/74       Y     0.425   PB   7
  Zhang [@pone.0065863-Zhang2]                    2007       China          Asian             143/124                68/54           59/58        16/12           195/166            91/82       Y     0.331   PB   8
  Li(b) [@pone.0065863-Li3]                       2005       China          Asian             321/147                92/40          167/69        62/38           351/149           291/145      Y     0.493   PB   8
  Hu [@pone.0065863-Hu1]                          2006       China          Asian             135/124                60/54           59/58        16/12           179/166            91/82       Y     0.331   PB   7
  Gai [@pone.0065863-Gai1]                        2007       China          Asian             136/197                31/54           73/95        32/48           135/203           137/191      Y     0.485   PB   7
  Chen [@pone.0065863-Chen2]                      2007       China          Asian             109/378               25/104          52/219        32/55           102/427           116/329      N     0.435   PB   7
  Tan(b) [@pone.0065863-Tan2]                     2003       China          Asian             112/112                38/66           60/40        14/6            136/172            88/52       Y     0.232   PB   7
  Zhang [@pone.0065863-Zhang3]                    2005       China          Asian             111/150                32/51           52/72        27/27           116/174           106/126      Y     0.856   PB   7
  You [@pone.0065863-You1]                        2000       China          Asian              98/110                25/31           47/52        26/27           97/114            99/106       Y     0.482   PB   7
  Jing [@pone.0065863-Jing1]                      2006       China          Asian             354/384               96/106          152/163      106/115          344/375           364/393      N     0.512   PB   8
  Sun [@pone.0065863-Sun3]                        2003       China          Asian             117/151                41/51           56/78        20/22           138/180           96/122       Y     0.404   PB   7
  Zhang [@pone.0065863-Zhang4]                    2001       China          Asian              146/79                36/18          101/50        9/11            173/86            119/72       N     0.456   PB   8
  Dou [@pone.0065863-Dou1]                        2009       Japan          Asian            2092/2810              480/679        1081/1380     531/751         2041/2738         2143/2882     Y     0.513   PB   9
  Song (a) [@pone.0065863-Song1]                  2011       China          Asian             122/104                17/26           78/49        27/29           112/101           132/107      Y     0.514   PB   9
  Song (b) [@pone.0065863-Song1]                  2011       China          Asian              102/92                34/18           40/43        28/31           108/79            96/105       Y     0.571   PB   9
  Liu [@pone.0065863-liu1]                        2009       China          Asian             269/229                93/67          106/100       70/62           292/234           246/224      Y     0.489   PB   8
  Huang (a) [@pone.0065863-Huang1]                2005       China          Asian              96/87                 18/20           57/47        21/20            93/87             99/87       Y     0.500   PB   8
  Huang (b) [@pone.0065863-Huang1]                2005       China          Asian              34/151                9/37            21/97        4/17            39/171            29/131       N     0.434   PB   8
  Lu [@pone.0065863-Lu2]                          2009       China          Asian             162/180                48/52          94/101        20/27           190/205           134/155      Y     0.431   PB   7
  Li(c) [@pone.0065863-Li4]                       2005       China          Asian             310/151                89/42          161/70        60/39           339/154           281/148      Y     0.490   PB   8
  Zhao [@pone.0065863-Zhao4]                      2009       China          Asian             331/293               117/52          179/137      35/104           413/241           249/345      Y     0.589   PB   7
  Wang [@pone.0065863-Wang3]                      2011       China          Asian              92/110                30/34           50/70        12/6            110/138            74/82       N     0.373   PB   7
  Wang [@pone.0065863-Wang4]                      2003       China          Asian             408/140               131/39          182/66        95/35           444/144           372/136      Y     0.486   PB   7
  Li (a) [@pone.0065863-Li5]                      2006       China          Asian             334/267                59/54          149/113      126/100          267/221           401/313      N     0.586   PB   8
  Huang [@pone.0065863-Huang3]                    2007       China          Asian             502/489               142/135         257/252      103/102          541/522           463/456      Y     0.466   PB   8
  Li (b) [@pone.0065863-Li6]                      2006       China          Asian             268/218                47/48          132/85        89/85           226/181           310/255      N     0.585   PB   7
  Dai [@pone.0065863-Dai1]                        2002       China          Asian             133/257                28/70          73/127        32/60           129/267           137/247      Y     0.481   PB   7
  Zhang [@pone.0065863-Zhang5]                    2006       China          Asian             100/100                19/32           46/53        35/15           84/117            116/83       Y     0.415   PB   7
  Yang [@pone.0065863-Yang1]                      2007       China          Asian             170/196                53/60          98/118        19/18           204/238           136/154      N     0.393   PB   8
  Li [@pone.0065863-Li1]                          2003       China          Asian             641/370               119/85          313/157      209/128          551/327           731/413      N     0.558   PB   8
  Liu [@pone.0065863-Liu1]                        2003       China          Asian             163/339               50/125          79/157        34/57           179/407           147/271      Y     0.400   PB   8
  Tan(a) [@pone.0065863-Tan3]                     2003       China          Asian              40/31                 11/14           25/15         4/2             47/43             33/19       Y     0.306   HB   7

HT, hypertension; SOC, source of control; PB, population-based, controls were blood donors, healthy controls matched for age, gender and domicile and participants in an health service programme from the same geographical region without clinically detectable hypertension; HB, hospital-based, controls were patients admitted to hospital without hypertension matched for age, gender and domicile; HWE, Hardy--Weinberg equilibrium; and MAF, minor allele frequency; Three publications [@pone.0065863-Ishikawa1]--[@pone.0065863-Huang1] contained more than one independent population, therefore, we considered them as different studies. Two studies [@pone.0065863-Khamidullaeva1], [@pone.0065863-Izawa1] were limited to the relationship in males. The samples [@pone.0065863-Dong1], [@pone.0065863-Larson1] were from individuals of African descent.

10.1371/journal.pone.0065863.t002

###### The main characteristics of the included studies regarding association between the *GNB3* C825T polymorphism and stroke.
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  Author                                Year   Country   Ethnicity   Sample sizeStroke/Control, n   Stroke/Control, n   Stroke/Control, n   HEWY/N    T frequency in control   SOCPB/HB   Score               
  ------------------------------------ ------ --------- ----------- ------------------------------ ------------------- ------------------- --------- ------------------------ ---------- ------- ------- ---- ---
  Zhang [@pone.0065863-Zhang1]          2005    China      Asian               922/1124                  212/244             512/569        198/311          936/1057          908/1191     Y     0.530   PB   8
  Morrison [@pone.0065863-Morrison1]    2001   America   Caucasian             990/1124                  266/311             512/569        212/244         1044/1191          936/1057     Y     0.470   PB   9
  Zhao [@pone.0065863-Zhao1]            2001    China      Asian               294/280                    89/93              144/133         61/54           322/319           266/241      Y     0.430   PB   7
  Tan [@pone.0065863-Tan1]              2003    China      Asian               100/100                    32/65               58/32          10/3            122/162            78/38       Y     0.190   PB   7
  Wang [@pone.0065863-Wang1]            2011    China      Asian                80/110                    26/34               46/70           8/6             98/138            62/82       N     0.373   PB   7
  Zhao [@pone.0065863-Zhao3]            2000    China      Asian               715/668                   196/195             348/338        171/135          740/728           690/608      Y     0.455   PB   8
  Li [@pone.0065863-Li1]                2003    China      Asian               144/352                    36/64              70/175         38/113           142/303           146/401      Y     0.570   PB   7
  Zhao [@pone.0065863-Zhao2]            2004    China      Asian               182/190                    35/55               87/92          60/43           157/202           207/178      Y     0.468   PB   7

HT, hypertension; SOC, source of control; PB, population-based, controls were blood donors, healthy controls matched for age, gender and domicile and participants in an health service programme from the same geographical region without clinically detectable hypertension; HB, hospital-based, controls were patients admitted to hospital without hypertension matched for age, gender and domicile; HWE, Hardy--Weinberg equilibrium; and MAF, minor allele frequency. Five studies [@pone.0065863-Morrison1], [@pone.0065863-Zhang1], [@pone.0065863-Zhao1]--[@pone.0065863-Wang1] regarding the association of the GNB3 C825T polymorphism and ischemic stroke were identified while one [@pone.0065863-Zhao2] was regarding cerebral hemorrhage and the other two [@pone.0065863-Zhao3], [@pone.0065863-Li1] included ischemic stroke or cerebral hemorrhage cases.

Of the 66 studies, eight compared males and females to assess an association between the *GNB3* C825T polymorphism and hypertension. Among these articles, three publications [@pone.0065863-Ishikawa1]--[@pone.0065863-Huang1] contained more than one independent population, and thus, we considered them as different studies that should be counted twice. Two studies [@pone.0065863-Zeltner1], [@pone.0065863-Chen1], which did not supply all of the required information regarding case or control genotypes were excluded from this meta-analysis. We only retrieved information on hypertensive patients and controls without diabetes mellitus from three studies [@pone.0065863-Kato1]--[@pone.0065863-Sun2]. Five studies [@pone.0065863-Morrison1], [@pone.0065863-Zhang1], [@pone.0065863-Zhao1]--[@pone.0065863-Wang1] regarding the association of the *GNB3* C825T polymorphism and ischemic stroke were identified while one [@pone.0065863-Zhao2] was regarding cerebral hemorrhage and the other two [@pone.0065863-Zhao3], [@pone.0065863-Li1] included ischemic stroke or cerebral hemorrhage cases.

All of the included studies were case-controlled in design. The main characteristics of the included studies are summarized in [Tables 1](#pone-0065863-t001){ref-type="table"}--[3](#pone-0065863-t003){ref-type="table"}. In all of the included studies, genotyping was analyzed via polymerase chain reaction and restriction fragment length polymorphisms. Stroke cases were evaluated by strict neurological examination: computed tomography, nuclear magnetic resonance imaging or both.

10.1371/journal.pone.0065863.t003

###### The association between the *GNB3* C825T polymorphism and hypertension among males and females.
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                                                                                 Male(HT/Control),n   Female(HT/Control),n                                                                                 
  ---------------------------------------------- ------ ----------- ----------- -------------------- ---------------------- --------- ---------- ---------- --------------- --------- -------- ----------- ---------
  Khamidullaeva [@pone.0065863-Khamidullaeva1]    2011     Uzbek       Asian            64/0                 93/50            17/10     221/50     127/70    Not available                                 
  Hui [@pone.0065863-Hui1]                        2007     Japan       Asian           57/50                 69/100           44/32    183/200    157/164        21/22        46/48    24/19     88/101     94/117
  Tsai [@pone.0065863-Tsai1]                      2000     China       Asian           28/21                 70/39            30/30     126/81     130/99        29/22        79/57    58/30     137/101    195/117
  Holmen [@pone.0065863-Holmen1]                  2010    Norway     Caucasian        404/245               340/194           58/41    1148/684   456/276       459/385      340/271   58/39    1258/1041   456/349
  Buchmayer [@pone.0065863-Buchmayer1]            2000   Australia   Caucasian         40/33                 36/43            11/11    116/109     58/65         45/39        34/42     8/6      124/120     50/54
  Suwazono [@pone.0065863-Suwazono1]              2006     Japan       Asian           35/180                90/372          30/171    160/732    150/714       12/165       31/347    20/117    55/677     71/581
  Suwazono [@pone.0065863-Suwazono2]              2004     Japan       Asian           58/300               135/614          63/282    251/1214   261/1178      20/274       36/602    20/217    76/1150    76/1036
  Izawa [@pone.0065863-Izawa1]                    2003     Japan       Asian          138/159               291/261          145/113   567/579    581/487    Not available                                 

HT, hypertension.

Quantitative Synthesis {#s3b}
----------------------

All models concerning the association of the *GNB3* C825T polymorphism and hypertension or stroke were identified using the random effects model for I^2^\>50%, which suggested significant heterogeneity. However, in most of the models, I^2^ was ≥70%, which indicated high heterogeneity [@pone.0065863-Higgins2], thus we pooled the ORs because of the significant results. The main results of this meta-analysis are presented in [Tables 4](#pone-0065863-t004){ref-type="table"} and [5](#pone-0065863-t005){ref-type="table"}. A significant overall association between the *GNB3* C825T polymorphism and the risk of hypertension was only detected in the allelic model (OR = 1.07, 95% CI = 1.01--1.13). No evidence of significance was identified in the dominant model (OR = 1.08, 95% CI = 0.98--1.81) or the recessive model (OR = 1.05, 95% CI = 0.97--1.14). However, none of the comparison models found an association between the *GNB3* C825T polymorphism and stroke (allelic model: OR = 1.11, 95% CI = 0.94--1.32; dominant model: OR = 1.16, 95% CI = 0.92--1.48; and recessive model: OR = 1.05, 95% CI = 0.97--1.14, respectively) ([Figure 2](#pone-0065863-g002){ref-type="fig"}). After excluding the outlier studies identified by the Galbraith plots, heterogeneity was effectively nonexistent or decreased and the pooled ORs were similar to those when the outlier studies regarding stroke cases were included; however, the association to hypertension was significant using the dominant model (OR = 1.05, 95% CI = 1.00--1.11). These results suggested that carriers of the T allele or TT genotype may have a higher risk of hypertension than non-carriers; however, the *GNB3* C825T polymorphism was not a risk factor for stroke.

![A forest plot for (A) the allelic model (T allele vs. C allele), (B) the dominant model (GG+GA vs. AA), and (C) the recessive model (TT vs. CT+CC).\
Random effects models were used with I^2^ values of 81, 76, and 71%. No evidence of association between the *GNB3* C825T polymorphism and stroke were detected in the allelic model (OR = 1.11, 95% CI = 0.94--1.32), dominant model (OR = 1.16, 95% CI = 0.92--1.48), or recessive model (OR = 1.08, 95% CI = 0.84--1.38).](pone.0065863.g002){#pone-0065863-g002}

10.1371/journal.pone.0065863.t004

###### The main results of meta-analysis of the association between the *GNB3* C825T polymorphism and hypertension.

![](pone.0065863.t004){#pone-0065863-t004-4}

                                                        T allele vs. C allele (allelic model)   TT+CT vs. CC (dominant model)   TT vs. CT+CC (recessive model)                                                            
  ---------------------------------------------------- --------------------------------------- ------------------------------- -------------------------------- ------------------ ------ ----- ------------------ ------ -----
  Overall                                                         1.07 (1.01,1.13)                          0.02                             71%                 1.08 (0.98,1.81)   0.11   74%   1.05 (0.97,1.14)   0.23   58%
  Excluding outlier studies                                       1.03 (1.00,1.06)                          0.06                              0%                 1.05 (1.00,1.11)   0.03   0%    1.00 (0.95,1.05)   0.92   0%
  Male                                                            0.93 (0.79,1.11)                          0.43                             71%                 1.01 (0.80,1.28)   0.92   59%   1.02 (0.87,1.18)   0.82   45%
  Female                                                          1.11 (0.99,1.24)                          0.08                              0%                 1.05 (0.90,1.24)   0.53   0%    1.35 (1.07,1.70)   0.01   0%
  Caucasian                                                       1.18 (1.00,1.39)                          0.05                             76%                 1.22 (0.97,1.54)   0.09   79%   1.10 (0.90,1.34)   0.36   20%
  Asian                                                           1.05 (0.99,1.11)                          0.12                             68%                 1.05 (0.94,1.16)   0.39   72%   1.04 (0.95,1.15)   0.37   63%
  HWE                                                                                                                                                                                                                     
  Y                                                               1.03 (0.97,1.10)                          0.32                             68%                 1.04 (0.96,1.14)   0.34   58%   1.02 (0.93,1.11)   0.71   52%
  N                                                               1.18 (1.06,1.33)                          0.004                            70%                 1.13 (0.86,1.48)   0.39   88%   1.19 (0.96,1.47)   0.11   71%
  Source of control                                                                                                                                                                                                       
  HB                                                              1.07 (0.99,1.16)                          0.07                              0%                 1.15 (0.92,1.44)   0.23   35%   1.11 (0.89,1.39)   0.34   17%
  PB                                                              1.07 (1.00,1.13)                          0.05                             74%                 1.07 (0.97,1.18)   0.21   76%   1.04 (0.96,1.14)   0.34   62%
  Normal population[\*](#nt105){ref-type="table-fn"}              1.04 (0.97,1.12)                          0.25                             69%                 1.05 (0.96,1.16)   0.30   61%   1.03 (0.93,1.14)   0.57   59%
  Score≥8                                                         1.08 (1.01,1.16)                          0.03                             76%                 1.07 (0.97,1.18)   0.20   75%   1.03 (0.97,1.11)   0.34   32%

*p*, a *p*-value of combined effect; CI, confidence interval;

, We conducted the analyses by limiting the studies according to the HWE and excluding those that included myocardial infarction, obesity, or diabetes mellitus in the cases or controls.

10.1371/journal.pone.0065863.t005

###### The main results of meta-analysis of association between the *GNB3* C825T polymorphism and stroke.

![](pone.0065863.t005){#pone-0065863-t005-5}

                               T allele vs. C allele (allelic model)   TT+CT vs. CC (dominant model)   TT vs. CT+CC (recessive model)                                                            
  --------------------------- --------------------------------------- ------------------------------- -------------------------------- ------------------ ------ ----- ------------------ ------ -----
  Overall                                1.11 (0.94,1.32)                          0.22                             81%                 1.16 (0.92,1.48)   0.21   76%   1.08 (0.84,1.38)   0.54   71%
  Excluding outlier studies              1.06 (0.97,1.15)                          0.20                              0%                 1.05 (0.94,1.17)   0.36   13%   1.11 (0.96,1.29)   0.16   34%
  Asian                                  1.15 (0.92,1.43)                          0.22                             84%                 1.21 (0.89,1.63)   0.23   79%   1.13 (0.82,1.56)   0.45   76%
  Ischemic stroke                        1.50 (1.12,2.00)                          0.28                             84%                 1.24 (0.89,1.73)   0.21   81%   1.01 (0.74,1.38)   0.95   68%
  HWE (Y)                                1.12 (0.93,1.34)                          0.23                             84%                 1.19 (0.92,1.54)   0.18   79%   1.05 (0.82,1.35)   0.68   74%
  Score≥8                                0.99 (0.85,1.14)                          0.85                             73%                 1.01 (0.90,1.15)   0.81   0%    0.95 (0.70,1.29)   0.74   83%

*p*, a *p*-value of combined effect; CI: confidence interval.

We also performed a meta-analysis to detect any association between males and females; however, only the recessive model (OR = 1.35, 95% CI = 1.07) identified a risk of hypertension among females.

In the cumulative meta-analysis by year of publication, the ORs and 95% CIs became more stable ([Figure 3](#pone-0065863-g003){ref-type="fig"}). Study by Benjafield et al. [@pone.0065863-Benjafield1] was the first publication to report a significant association between the *GNB3* C825T polymorphism and hypertension and triggered the identification of subsequent related studies that tried to replicate the initial results. In the allelic, dominant, and recessive models, the study by Benjafield et al. [@pone.0065863-Benjafield1] was the most influential and made the overall estimation more significant in the present cumulative meta-analysis. After the study by Dou et al. [@pone.0065863-Dou1] was included, the overall estimation became more accurate for the larger sample size.

![A cumulative plot by publication year for (A) the allelic model, (B) the dominant model, and (C) the recessive model.\
The ORs and associated 95% CIs became more stable over time. The study by Benjafield et al. [@pone.0065863-Benjafield1] was the first report to show a significant association between the *GNB3* C825T polymorphism and the risk of hypertension, and this study likely influenced the overall estimation.](pone.0065863.g003){#pone-0065863-g003}

Subgroup Analysis {#s3c}
-----------------

To further clarify heterogeneity among the studies, we performed subgroup analysis. Regarding the hypertension study population, the status of the HWE and the source of control had a critical role in heterogeneity (detailed data is presented in [Table 4](#pone-0065863-t004){ref-type="table"}). Interestingly, only the allelic model, which was not consistent with the HWE, yielded a marginally significant risk of hypertension (OR = 1.18, 95% CI = 1.06--1.33), but no evidence of an association was found in the source of the control studies (controls were population-based or hospital-based).

Only one publication regarding Caucasians was screened in an analysis of the association between the *GNB3* C825T polymorphism and stroke, and all of the control sources were population-based, thus we did not perform subgroup analysis by ethnicity. Similarly, there were only two studies regarding an African population and hypertension, further indicating that subgroup analysis by ethnicity was to be avoided.

Sensitivity Analysis {#s3d}
--------------------

To further strengthen the confidence of the results of this meta-analysis, sensitivity analysis was conducted by limiting the included studies with NOS scores ≥8 or restricted analysis on hypertension populations according to the HWE and without other diseases or only included Asian and/or Caucasian populations. All comparative models found no association with hypertension, which suggested that the T allele or TT genotype may not be a risk factor for hypertension (detailed data is presented in [Table 4](#pone-0065863-t004){ref-type="table"}). Importantly, the sensitivity analysis results were slightly out of agreement with those of the initial analysis; therefore, the results should be interpreted cautiously.

As to the association of stroke, when we restricted the analyses by limiting the included studies according to the HWE, the recalculated pooled OR values did not alter the initial results, suggesting that the TT genotype or T allele was not a risk factor of stroke (detailed data are presented in [Table 5](#pone-0065863-t005){ref-type="table"}). Similarly, when we evaluated the ischemic stroke population or Asian population, no evidence of statistical association was obtained.

Publication Bias {#s3e}
----------------

Funnel plots were constructed and the Egger\'s test was performed to assess publication bias of the studies. Funnel plots should be symmetrical when no publication bias exists ([Figures 4](#pone-0065863-g004){ref-type="fig"} and [5](#pone-0065863-g005){ref-type="fig"}). Regarding the hypertension population, only the recessive model displayed an asymmetric funnel plot, while the Egger\'s regression test confirmed the presence of moderate publication bias (*p* = 0.043). No statistical evidence of publication bias was identified regarding the *GNB3* C825T polymorphism and its association with stroke.

![Funnel plots for the *GNB3* C825T polymorphism and its association with hypertension.\
(A) the allelic model (T allele vs. C allele, *p* = 0.150), (B) the dominant model (TT+CT vs. CC, *p = *0.565), and (C) the recessive model (TT vs. CT+CC, *p = *0.043). The funnel plots should be symmetrical when no publication bias occurs; however, the funnel plot of the recessive model was asymmetrical (*p* = 0.043), suggesting publication bias. The other two were symmetrical (*p = *0.150 and 0.565, respectively). SE, standard error; OR, odds ratio.](pone.0065863.g004){#pone-0065863-g004}

![Funnel plots for the *GNB3* C825T polymorphism and its association with stroke.\
(A) the allelic model (T allele vs. C allele, *p = *0.145), (B) the dominant model (TT+CT vs. CC, *p = *0.281), and (C) the recessive model (TT vs. CT+CC, *p = *0.116). The funnel plots should be symmetrical when no publication bias occurs. No evidence of publication bias was detected in the three models. SE, standard error; OR, odds ratio.](pone.0065863.g005){#pone-0065863-g005}

Discussion {#s4}
==========

Stroke is a significant event that leads to increased mortality and morbidity and hypertensive individuals reportedly have a greater incidence of stroke than normotensive individuals. Genetic factors as well as obesity, high sodium intake, physical inactivity, low potassium diets, and alcohol consumption contribute to the occurrence of hypertension, and essential hypertension status may play a role in the etiology of stroke either through effects on blood pressure levels or through separate pathways [@pone.0065863-Morrison1], [@pone.0065863-Montasser1]. The established relationship between hypertension and stroke suggested that these disorders may have at least some genes in common. Recently, several studies reported that the *GNB3* 825T polymorphism was associated with an increased risk of hypertension, obesity, metabolic syndrome, atherosclerosis, and diabetes mellitus. Besides, the *GNB3* 825T allele was found to significantly increase the risk of clinical ischemic stroke in Caucasians, but not subclinical cerebral infarct [@pone.0065863-Zhang1], [@pone.0065863-Chistiakov1]. However, the present meta-analysis was designed to confirm the association between the *GNB3* C825T polymorphism and essential hypertension or stroke.

Overall, our meta-analytical results showed that the *GNB3* 825T allele had a weak association with essential hypertension. However, after we restricted the studies according to the HWE and included only those without other diseases, such as diabetes and myocardial infarction, all of the compared models failed to identify an association between the *GNB3* 825T allele and hypertension. Similarly, when we performed sensitivity analysis with the inclusion criteria of "Asian" or "Caucasian," no evidence of an association was obtained, which might be due to heterogeneity between the studies. Besides, the funnel plot was asymmetric in the recessive model for *p* = 0.043, so publication bias must also be considered. In addition, our results were consistent with those reported in previous studies [@pone.0065863-Niu1], [@pone.0065863-Lu1], but were slightly less discrepant with others [@pone.0065863-Bagos1], which might have resulted from the greater number of studies included in our meta-analysis. However, there were only two studies concerning an African population, thus a larger sample size is needed to further address the relationship between the *GNB3* C825T polymorphism and essential hypertension in Africans.

Interestingly, the *GNB3* C825T polymorphism was not associated with stroke. When we retrieved studies on ischemic stroke cases or limited the studies according to the HWE or an NOS score of ≥8, similar results were obtained, suggesting that our initial results were reliable and in line with most of the included studies. But, considering that most of the included stroke patients were Asian, our results cannot be directly used to extrapolate a correlation between the GNB3 c825T polymorphism and stroke in Caucasians, Africans, or other ethnicities.

In addition, we tested the T allele frequency in controls (hypertensive population) ([Table 1](#pone-0065863-t001){ref-type="table"}), and found that there was statistical significance between Asian, Caucasian, and African groups (*p* = 0.0001). This result was in agreement with a previous study [@pone.0065863-Siffert3] that reported varied frequencies of the T allele among different ethnic groups, in which the highest rate occurred in Africans (T = 79%), followed by Asians (T = 46%), and then Caucasians (T = 33%). However, no statistical significance was found between males and females (*p* = 0.337). Therefore, it is likely that a higher T allele frequency is not necessarily indicative of an increased occurrence of hypertension.

Generally, the *GNB3* 825T allele was only slightly associated with an increased risk of essential hypertension compared to non-carriers. But, the *GNB3* C825T polymorphism failed to contribute to the risk of stroke, thus it was clear that the polymorphism contributed to hypertension and stroke differently. Therefore, gene-gene interactions should be taken into consideration. Until now, \>500 candidate genes for hypertension have been suggested from a variety of genetic studies, and this number continues to increase [@pone.0065863-Kuo1], but not all of these genes were associated with an increased risk of stroke. Distribution of the C825T genotypes varies greatly in different ethnicities and the frequency of the T allele is highest in Africans, lowest in Caucasians, and intermediate in Asians. However, the CC genotype is rare in Africans and the distribution of East Asian genotypes is roughly 25% TT, 50% TC, and 25% CC [@pone.0065863-Siffert1]. Thus, individuals from different ethnicities may develop cardiovascular disorders, such as hypertension or stroke, which more or less differ in pathogenesis/pathophysiology of a given disorder due to different genetic backgrounds. In our meta-analysis, individual studies on Africans, Asians, and other ethnicities were deficient; therefore, additional evidence regarding the correlation of the *GNB3* C825T polymorphism with hypertension or stroke is required. The interactions between environmental and genetic factors constitute a key issue in the pathogenesis of hypertension and stroke. Most of the susceptibility genes for common diseases such as hypertension do not have a strong primary etiological role in disease predisposition, but rather code response elements to exogenous environmental factors. Therefore, a genetic marker may have only a modest affect on calculating risk in individuals who minimize exposure to environmental factors, but a major effect in individuals exposed to high-risk environment factors [@pone.0065863-Sarzynski1]. Young et al. [@pone.0065863-Young1] reported that latitude was an ecological factor that affected blood pressure via temperature and humidity. Likewise, *GNB3* presents a number of functional alleles that influence hypertension susceptibility. Therefore, those populations that have a high prevalence of the *GNB3* 825T allele also have a higher prevalence of heat-adapted alleles at other SNPs. Physical inactivity, increased body mass, obesity, and smoking may also influence the risk of hypertension and stroke differently.

In addition to race, gender also seems to be an important risk factor for adverse cardiovascular events, such as hypertension and stroke. Suwazono et al. [@pone.0065863-Suwazono1] reported that the 825T allele was an independent risk factor for hypertension in Japanese females, whereas Beige et al. [@pone.0065863-Brand1] found that the T allele in males was associated with higher blood pressure. In our analysis, the *GNB3* TT genotype was marginally associated with hypertension among females, and no evidence of an association with hypertension was found in males. In the cumulative meta-analysis, three models showed evidence of a non-association between *GNB3* alleles and hypertension or stroke. Two primary causes may account for this discrepancy. First, females have dominant parasympathetic and subordinate sympathetic activities compared to males, and, secondly, estrogen plays an important role in gender-related differences in the autonomic nervous system [@pone.0065863-Suwazono1]. Thus, it seems that different automatic functions between genders altered the association of the *GNB3* 825T allele with hypertension.

Some limitations of the present meta-analysis should be considered. Firstly, all of the included studies mostly involved Caucasians and Asians, thus studies on other ethnic populations are needed. Secondly, all of the included studies were case-controlled and all of the cases involved survivors of hypertension and stroke. Finally, the number of stroke cases were limited and had relatively weak statistical power to detect potential risks of the *GNB3* C825T polymorphism. Thus, more population-based studies with large sample sizes are required. Despite these limitations, this meta-analysis was designed to overcome the limitations of individual studies, thus the results should be more reliable. Since the *GNB3* C825T polymorphism appears to be a useful marker to predict the relative risk of diseases, such as hypertension and stroke, this meta-analysis is better suited in a preventive aspect to identify certain genotypes that will be most likely to benefit from pharmacological interventions.

In summary, the overall analysis of available evidence suggested that the *GNB3* 825T allele may be a good indicator of hypertension; however, it had no association with hypertension in Asians and Caucasians and there was lack of evidence to support an association with stroke in Asians. Therefore, multiethnic studies with much larger sample-sizes are required to better evaluate the association between the *GNB3* C825T polymorphism and hypertension or stroke.
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